Trending Now
AAVantgarde’s AAVB-039 gene therapy to treat Stargardt disease receives orphan drug status from FDA | Ophthalmology Times
Q&A: The ARCHER trial and the importance of continued GA research | Ophthalmology Times
Q&A: Frank Holz shares how innovation showcased at EURETINA brings hope for patients with GA | Ophthalmology Times
Breaking News
Surgical innovation in dry eye disease: Salivary gland transplant
Ağustos 27, 2025
Next-generation IOLs advance complex cataract care
Ağustos 26, 2025
OCT changes with low-level red light therapy for myopia in children
Ağustos 26, 2025
Alcon presenting at APACRS 2025
Ağustos 21, 2025
Breaking News
Popular Now
FDA grants breakthrough therapy designation to Nacuity’s NPI-001 for retinitis pigmentosa | Ophthalmology Times
(Image Credit: AdobeStock) The US Food and Drug Administration (FDA) has granted…
AAVantgarde’s AAVB-039 gene therapy to treat Stargardt disease receives orphan drug status from FDA | Ophthalmology Times
(Image Credit: AdobeStock/artacet) The US Food and Drug Administration (FDA) has granted…
Q&A: The ARCHER trial and the importance of continued GA research | Ophthalmology Times
(Image credit: AdobeStock/J Bettencourt) In conversation with Sydney M. Crago, Managing Editor…
Charles Miller, MD, PhD, on DME research and the initiation of the phase 2b/3 BRUNELLO trial | Ophthalmology Times
Image credit: AdobeStock/MrAshi On September 4, 2025, Merck and EyeBio announced that…
Collaborate With Us
Join forces with Ophthalmology News to reach a global community of eye care professionals. Whether you want to contribute an article, share research, or explore partnership opportunities, we’d love to hear from you.
Editor Choice
MacuMira launches first Health Canada-approved device for AMD treatment | Ophthalmology Times
(Image Credit: AdobeStock) Canadian medical device company MacuMira Medical Devices recently introduced…
EyeCon 2025 celebrates Visionary in Eye Care Resident Award winners | Ophthalmology Times
The recipients of this year’s Visionary in Eye Care Resident Recognition Awards…
STAAR and Broadwood clash over proposed Alcon merger | Ophthalmology Times
(Image Credit: AdobeStock) STAAR and Broadwood Partners have recently pleaded their case…
Q&A: Anat Loewenstein on the Ramin Tadayoni Award | Ophthalmology Times
Photo of Anat Loewenstein, MD, who served as the 2025 EURETINA president…
New study links rising myopia rates in China to environmental factors | Ophthalmology Times
A new epidemiology study published in the British Journal of Ophthalmology reported…
Study finds no change in smooth pursuit eye movement velocity after 1 season of college football | Ophthalmology Times
A study of the effects of repetitive impacts to the head during…
Q&A: Daniela Bacherini discusses using ultra widefield OCT to evaluate peripheral retinal degenerations | Ophthalmology Times
Photo of Daniela Bacherini at the 2025 EURETINA meeting Daniela Bacherini, MD,…
Looking ahead: Ophthalmologists envision a world without the toughest diseases | Ophthalmology Times
As Ophthalmology Times celebrates its 50th anniversary, we took the opportunity to…
Q&A: Boris Stanzel on the use of methotrexate in PVR cases | Ophthalmology Times
Photo of Boris Stanzel, MD, at the 2025 EURETINA meeting Professor Boris…
Worth Reading
Meeting expectations with evolving technology
Ağustos 26, 2025
/ Patient Education, Research & Studies, Technology & Innovation, Treatments & Surgery
Unpacking high-yield ophthalmology tips and clinical pearls, with Nicole Bajic, MD
Ağustos 26, 2025
/ Industry News, Patient Education, Research & Studies, Treatments & Surgery
Possible protective role of cannabis in preventing postoperative proliferative vitreoretinopathy after retinal detachment repair
Ağustos 26, 2025
/ Patient Education, Research & Studies
Next-generation IOLs advance complex cataract care
Ağustos 26, 2025
/ Patient Education, Research & Studies, Treatments & Surgery
Subscribe Now
Enter your email address below and subscribe to our newsletter